for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

AddLife AB

ALIFb.ST

Latest Trade

236.00SEK

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

184.18

 - 

307.00

As of on the Stockholm Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
236.00
Open
--
Volume
--
3M AVG Volume
0.22
Today's High
--
Today's Low
--
52 Week High
307.00
52 Week Low
184.18
Shares Out (MIL)
28.06
Market Cap (MIL)
6,509.98
Forward P/E
42.93
Dividend (Yield %)
0.93

Next Event

Full Year 2019 AddLife AB Earnings Call

Latest Developments

More

AddLife Q3 EBITA Up At SEK 65 Million

AddLife Acquires Lab-Vent Controls A/S And Koldt & Ryø El A/S

AddLife Q2 EBITA Rises To SEK 68 Million

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About AddLife AB

AddLife AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The Company operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The Company operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.

Industry

Biotechnology & Drugs

Contact Info

Birger Jarlsgatan 43

+46.8.42003830

https://www.add.life/

Executive Leadership

Johan Sjo

Independent Chairman of the Board

Kristina Willgard

President, Chief Executive Officer

Martin Almgren

Chief Financial Officer

Lars-Erik Rydell

Business Area Manager, Medtech

Peter Simonsbacka

Business Area Manager, Labtech

Key Stats

Price To Earnings (TTM)
46.21
Price To Sales (TTM)
2.05
Price To Book (MRQ)
4.57
Price To Cash Flow (TTM)
19.58
Total Debt To Equity (MRQ)
65.45
LT Debt To Equity (MRQ)
8.93
Return on Investment (TTM)
9.98
Return on Equity (TTM)
5.25

Latest News

Latest News

BRIEF-Addlife Q1 EBITA Up At SEK 57 Million

* Q1 NET SALES SEK 597 MILLION VERSUS SEK 576 MILLION YEAR AGO

BRIEF-AddLife Acquires Ossano Scandinavia AB

* SIGNED AN AGREEMENT TO ACQUIRE ALL SHARES IN OSSANO SCANDINAVIA AB

BRIEF-Addlife AB Oct-Dec Net Sales Rose By 9 Percent To Sek 668 Million (611)

* OCT-DEC NET SALES ROSE BY 9 PERCENT TO SEK 668 MILLION (611)

BRIEF-AddLife says co's executive vice president Artur Aira has decided to resign

* AddLife ab says AddLife's executive vice president Artur Aira has decided to resign from company

BRIEF-Addlife Q2 net sales up at SEK 572 million ​

* Q2 EBITA SEK 57 MILLION VERSUS SEK 47 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Addlife Q1 net sales SEK 576 million

* Q1 NET SALES SEK 576 MILLION VERSUS SEK 453 MILLION YEAR AGO

BRIEF-AddLife acquires Norwegian Hepro Group

* Acquires Norwegian Hepro Group - three companies providing home care products and welfare technology

BRIEF-Addlife Oct-Dec EBITA up at 75.8 million

* Oct-Dec net sales 611.5 million Swedish crowns ($69 million)versus 472.1 million crowns year ago

BRIEF-AddLife acquires TM Techno Medica

* Has signed agreement to acquire all shares in TM Techno Medica AB

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up